Novel vasoconstrictor peptides, endothelin-1 (ET-1) and endothelin-3 (
ET-3), are also known as neuropeptides or neuromodulators. When either
ET-1 or ET-3 was administered to the rat striatum via a microinjectio
n needle, the dopamine release from the striatum dose-dependently incr
eased. Pretreatment with a glutamate receptor blocker, glutamate dieth
yl ester hydrochloride, inhibited the dopamine release induced by ET-3
, whereas it further enhanced the dopamine release by ET-1. This sugge
sts that ET-1 directly induces the dopamine release, whereas the actio
n of ET-3 is mediated by glutamate different distributions of endothel
in receptors: ET(A) receptors may be present on the dopaminergic neuro
ns, but ET(B) receptors on the glutamatergic neurons.